Results 141 to 150 of about 5,700,334 (377)
Fall 2016 - HIPS Newsletter [PDF]
, 2016 https://nsuworks.nova.edu/cahss_hips_newsletter/1002/thumbnail ...
Department of History and Political Science
core +1 more source
Introduction: Special Issue ‘Translating and translations in the history of science’
Annals of Science, 2016 Bettina Dietz
semanticscholar +1 more source
Section on Historical and Philological Sciences (L) and the History of Science Society [PDF]
, 1940 Sarah G. Mayer, Henry R. Viets
openalex +1 more source
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
Combining Theory and Practice in the Teaching of Science Institutions: A Collaborative Program between the City University of New York and the American Museum of Natural History [PDF]
, 2000 The National Science Education Standards contain several mandates that share the use of alternative and creative experiences in the teaching of science at all levels.
Espinoza, F.
core +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski +19 more
wiley +1 more source
History of Oceanography, Number 12 [PDF]
, 2000 Commission of Oceanography, Division of History of Science, International Union of the History and Philosophy of Science
core +9 more sources
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source